Key Takeaways
- • GP-led secondaries surpassed $100 billion in 2025 and have grown tenfold over the past decade, per Evercore Private Capital Advisory data cited in the piece, and now represent about 50% of total secondary volume, up from roughly 20% in 2015.
- • Continuation vehicle (CV) fund volume reached 16% of total private equity exit value in 2025, up from 5% in 2020, according to Morgan Stanley and LSEG data cited by Ares.
- • Ares says it is underwriting GP-led deals to 18%-20%+ gross returns, in line with primary buyout returns, and cites Ares CVs delivering roughly two-thirds fewer losses than the broader buyout market.
- • The GP-led market remains structurally undercapitalized, with roughly one year of dry powder against current deal volume, which Ares argues lets seasoned secondary managers be selective.
- • In GP-led deals, buyers capture value created between signing and closing because the price is set to net asset value at signing, a structural advantage Ares says is often not fully reflected in underwriting.
Summary
Ares attributes adoption to CVs serving as a structural liquidity tool that lets managers hold their highest-conviction investments. The firm cites Morgan Stanley and LSEG data showing CV exit volume reached 16% of total private equity exit value in 2025, up from 5% in 2020, and says about 83% of the top 100 buyout sponsors have accessed the CV market since inception. Ares also argues the use of GP-led secondaries has continued to grow even as Global M&A topped $5.1 trillion in 2025, with the GP-led market reaching an all-time high. It estimates roughly $5.7 trillion of unrealized private equity assets aged four to ten years remain candidates for secondaries investment, per Preqin.
On portfolio economics, Ares says GP-led deals are often underwritten to higher return targets and that it is currently underwriting to 18%-20%+ gross returns, in line with primary buyout returns. It states that investing in known, de-risked assets has contributed to lower loss ratios and return dispersion versus primary buyout funds, citing Ares CVs with roughly two-thirds fewer losses than the broader buyout market. The firm also cites Burgiss-based analysis from 1995 to 2025 showing private equity secondaries outperforming public equities by roughly 300-500 basis points over the long term, with milder drawdowns. Ares notes the market remains structurally undercapitalized, with around one year of dry powder against current deal volume.
Ares contrasts GP-led deals with LP-led secondaries, which typically span tens to hundreds of underlying companies and are described as providing broad diversification and a beta-like exposure driven largely by discounts. GP-led deals offer more targeted exposure to specific assets, sectors, or geographies, with returns driven by long-term compounding, which Ares characterizes as alpha-like. The piece also highlights a structural feature: because GP-led purchase prices are set at net asset value at signing, equity value created between signing and closing accrues to the buyer, unlike traditional M&A where the seller typically keeps those interim gains. Ares projects the secondaries market could reach $400 billion by 2029, implying the GP-led segment could exceed $200 billion within three years. The article is a promotional thought-leadership piece from Ares, and its performance claims carry the firm's stated disclaimers that past performance does not guarantee future results.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.